pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,257 catalysts · 4,970 phase readout · 2,346 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 17 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: earnings×type: recall×clear all
type
  • phase readout4,970
  • 8k filing2,346
  • earnings287
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT06979518: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry

    Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07234318: A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

    Sponsor: Laboratoires Thea. Phase: . Conditions: Dry Eye Disease (DED)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06290713: Vasodilator and Exercise Study for DMD (VASO-REx)

    Sponsor: University of Florida. Phase: PHASE2. Conditions: Duchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in Children, Vasodilation, Exercise, DMD

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05881460: Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2

    Sponsor: Synergic Medical Technologies, Inc.. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03910660: A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

    Sponsor: BioXcel Therapeutics Inc. Phase: PHASE1. Conditions: Prostate Cancer, Neuroendocrine Tumors, Small Cell Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07530523: KPAP vs EPR for Efficacy

    Sponsor: SleepRes Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05363280: Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

    Sponsor: Advenchen Pharmaceuticals, LLC.. Phase: PHASE2. Conditions: Small Cell Lung Cancer, Renal Cell Carcinoma (RCC), Non-Small Cell Lung

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04648280: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

    Sponsor: PENTA Foundation. Phase: PHASE1. Conditions: HIV Infections With Multi Drug Resistant Virus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07435779: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study

    Sponsor: Hebei Senlang Biotechnology Inc., Ltd.. Phase: EARLY_PHASE1. Conditions: UC

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05907096: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

    Sponsor: argenx. Phase: PHASE2. Conditions: Delayed Graft Function

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01897688: A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients

    Sponsor: Northwestern University. Phase: PHASE3. Conditions: Type 1 Diabetes, Severe Hypoglycemic Unawareness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05431088: A Phase 2/3 Study in Adult and Adolescent Participants With SCD

    Sponsor: Pfizer. Phase: PHASE2. Conditions: Sickle Cell Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

    Sponsor: Respirion Pharmaceuticals Pty Ltd. Phase: PHASE1. Conditions: Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04933903: BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

    Sponsor: Brown University. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07562061: mulTiplex Immunoassay qualiTy assuRance Panel

    Sponsor: St George's, University of London. Phase: . Conditions: Group B Strep Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00861705: Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598994: Topical Capsaicin Versus Diclofenac for Chronic Temporomandibular Joint-Related Pain

    Sponsor: Istanbul University. Phase: NA. Conditions: Temporomandibular Disorders (TMD), Temporomandibular Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07061366: The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study.

    Sponsor: Maxima Medical Center. Phase: . Conditions: Preterm, Monitoring

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03879694: Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

    Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Lung Atypical Carcinoid Tumor, Lung Typical Carcinoid Tumor, Metastatic Pancreatic Neuroendocrine Tumor

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06706622: A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

    Sponsor: H. Lundbeck A/S. Phase: PHASE3. Conditions: Multiple System Atrophy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03849651: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), NK-Cell Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma (NHL), Juvenile Myelomonocytic Leukemia (JMML), Chronic Myeloid Leukemia (CML)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07519551: Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Osteoporosis, Osteopenia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03466151: RESOLUTE ONYX China RCT Study

    Sponsor: Medtronic Vascular. Phase: NA. Conditions: Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04423029: A Study of DF6002 Alone and in Combination With Nivolumab

    Sponsor: Dragonfly Therapeutics. Phase: PHASE1. Conditions: Solid Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06958653: Gamified Digital Balance Assessment for Older Adults in Community Settings: Development, Validation, and User Experience Evaluation in a Mixed Methods Study

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: ELDERLY PEOPLE, Fall Prevention, Digital Health

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07402837: Creating a Flexible Curriculum Tool for Pediatric Palliative Care Rotating Learners

    Sponsor: Children's National Research Institute. Phase: NA. Conditions: Palliative Care Education

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05491837: Device-induced Intermittent Hypoxia in Persons With Incomplete Spinal Cord Injury

    Sponsor: Riphah International University. Phase: NA. Conditions: Incomplete Spinal Cord Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05479045: A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

    Sponsor: Georgetown University. Phase: PHASE2. Conditions: Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT07260045: The Effects of Chiropractic on Adults With Depression

    Sponsor: Life University. Phase: NA. Conditions: Depression Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07394972: Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency

    Sponsor: Nicole Stoffel. Phase: NA. Conditions: Iron Deficiency (Without Anemia)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05970172: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

    Sponsor: Astellas Pharma Global Development, Inc.. Phase: PHASE3. Conditions: Chronic Kidney Disease, Renal Anemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05979272: TECH App Marijuana Use Intervention for Court-Involved Adolescents

    Sponsor: Northwestern University. Phase: NA. Conditions: Cannabis Use, Adolescent

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03452072: Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds

    Sponsor: Brigham and Women's Hospital. Phase: PHASE2. Conditions: Wound of Skin, Wound Heal, Wound Open, Surgical Wound

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07135895: The ArtixASCEND Study

    Sponsor: Inari Medical. Phase: NA. Conditions: Acute Lower Limb Arterial Occlusion

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06040645: Outcomes of Urinary Incontinence Treatment in Primary Care: APP Co-Management and Electronic Consult

    Sponsor: University of California, San Diego. Phase: NA. Conditions: Urinary Incontinence

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06323772: Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

    Sponsor: University Hospital Tuebingen. Phase: . Conditions: Retinitis Pigmentosa

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06118372: Recombinant vWF Concentrate and ECMO

    Sponsor: University of Virginia. Phase: PHASE1. Conditions: Bleeding Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07431372: Validation of the Shared Happiness Index in Multidisciplinary Primary Care Practices ( Be aPi )

    Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Well Being

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05916495: An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant

    Sponsor: University of Manchester. Phase: NA. Conditions: Lung Transplant; Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06526195: Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

    Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07248839: A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers, Hepatic Impairment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02117375: EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05332275: A Media Parenting Prevention Intervention

    Sponsor: University of Florida. Phase: NA. Conditions: Substance Related Problem

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04138277: A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

    Sponsor: Amicus Therapeutics. Phase: PHASE3. Conditions: Pompe Disease (Late-onset)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03910075: Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)

    Sponsor: Virginia Polytechnic Institute and State University. Phase: PHASE3. Conditions: Perinatal Stroke, Hemiparesis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03998501: fMRI to Examine the Effect of CBTm to Increase Resiliency for PTSD

    Sponsor: University of Manitoba. Phase: NA. Conditions: Stress Disorders, Post-Traumatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05923801: Changing Tactics? Optimizing ECT in Difficult-to-treat Depression

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Depression

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06054230: Genomic Sequencing for Evaluation of Fetal Structural Anomalies

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Fetal Structural Anomalies

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05747430: SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

    Sponsor: iRenix Medical, Inc.. Phase: PHASE2. Conditions: Retinal Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07465328: Studying the Impairment of Stroke and Sarcopenia Patients Using Maximum Voluntary Contractions of the Leg Joints.

    Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Sarcopenia, Stroke

    full page →ctgov ↗
    ← prev
    page 81 of 106
    next →